Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 21,661 | 0 | N/A | N/A |
| TOTAL | $21,910 | $0 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 41 | 0 | N/A | N/A |
| Other Non-Current Assets | 122 | 0 | 0 | 0 |
| TOTAL | $163 | $N/A | $N/A | $N/A |
| Total Assets | $22,073 | $0 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 548 | 0 | 0 | 0 |
| Accrued Expenses | 1,887 | 0 | N/A | N/A |
| TOTAL | $2,435 | $0 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 95 | 0 | 0 | 0 |
| TOTAL | $95 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,530 | $0 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 10 | 0 | N/A | N/A |
| Retained earnings | -54,213 | 0 | N/A | N/A |
| Other shareholders' equity | 69,114 | 0 | 0 | 0 |
| TOTAL | $19,543 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $22,073 | $0 | $0 | $0 |